8 August 2025 – Harare, Zimbabwe / Cape Town & Durban, South Africa – African clinical research institutions, in partnership with global collaborators, have launched a Phase 1 clinical trial to evaluate a novel HIV vaccine candidate, GRAdHIVNE1. The trial is being conducted by Mutala Trust (Zimbabwe), the Desmond Tutu Health Foundation (DTHF), and the Africa […]
ACRN’s success in clinical trials is partly due to its collaborative approach with communities. This began over three years ago in Zimbabwe with the Mutala Trust, a key network partner of ACRN, and involves engaging communities in designing, developing, and sharing clinical trial results. This method has enhanced community understanding of research and increased stakeholder
Strengthening HIV Research & Innovation in Africa: ACRN Hosts Gates Foundation & IAVI in Zimbabwe From 5 to 7 February 2025, ACRN hosted senior HIV experts from the Gates Foundation and the International AIDS Vaccine Initiative (IAVI) in Harare, Zimbabwe.The visit aimed to: Assess Mutala’s preparedness for upcoming HIV vaccine trials.Strengthen ACRN’s clinical trials and
Strengthening HIV Research & Innovation in Africa Read More »
